Treatment and outcomes of acute basilar artery occlusion in the Basilar Artery International Cooperation Study (BASICS): a prospective registry study

[1]  M. Kaste,et al.  Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. , 2008, The New England journal of medicine.

[2]  Takashi Inoue,et al.  Randomized Trial of Intraarterial Infusion of Urokinase Within 6 Hours of Middle Cerebral Artery Stroke: The Middle Cerebral Artery Embolism Local Fibrinolytic Intervention Trial (MELT) Japan , 2007, Stroke.

[3]  A. Algra,et al.  The Basilar Artery International Cooperation Study (BASICS) , 2007, International journal of stroke : official journal of the International Stroke Society.

[4]  H. Diener,et al.  Distribution and outcome of symptomatic stenoses and occlusions in patients with acute cerebral ischemia. , 2006, Archives of neurology.

[5]  M. Kaste,et al.  Door to thrombolysis: ER reorganization and reduced delays to acute stroke treatment , 2006, Neurology.

[6]  H. Mattle,et al.  Therapy of Basilar Artery Occlusion: A Systematic Analysis Comparing Intra-Arterial and Intravenous Thrombolysis , 2006, Stroke.

[7]  A. Algra,et al.  Outcome in patients with basilar artery occlusion treated conventionally , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[8]  G. Hankey,et al.  Results of a Multicentre, Randomised Controlled Trial of Intra-Arterial Urokinase in the Treatment of Acute Posterior Circulation Ischaemic Stroke , 2005, Cerebrovascular Diseases.

[9]  G. Schroth,et al.  Clinical and radiological predictors of recanalisation and outcome of 40 patients with acute basilar artery occlusion treated with intra-arterial thrombolysis , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[10]  Scott Hamilton,et al.  Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials , 2004, The Lancet.

[11]  I. Bone,et al.  Basilar artery occlusion , 2004, Neurocritical care.

[12]  D. Leys,et al.  Atherothrombosis: A Major Health Burden , 2001, Cerebrovascular Diseases.

[13]  P. Akins,et al.  Intra-arterial prourokinase for acute ischemic stroke. , 2000, JAMA.

[14]  R. Higashida,et al.  Intra-arterial Prourokinase for Acute Ischemic Stroke: The PROACT II Study: A Randomized Controlled Trial , 1999 .

[15]  M. Kaste,et al.  Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II) , 1998, The Lancet.

[16]  S Greenland,et al.  A critical look at methods for handling missing covariates in epidemiologic regression analyses. , 1995, American journal of epidemiology.

[17]  Joseph P. Broderick,et al.  Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. , 1995 .

[18]  A. Ferbert,et al.  Clinical features of proven basilar artery occlusion. , 1990, Stroke.

[19]  H. Schouten,et al.  Interobserver agreement for the assessment of handicap in stroke patients. , 1988, Stroke.